<DOC>
	<DOCNO>NCT00947674</DOCNO>
	<brief_summary>This prospective , randomize , double-blind , sham treatment control multicenter study .</brief_summary>
	<brief_title>A Study Leukocytapheresis ( LCAP ) Patients With Ulcerative Colitis ( UC )</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Patients diagnose UC active stage base clinical symptom finding endoscopy Patients pancolitis type leftsided colitis type lesion 15 cm long observe endoscopically Patients Mayo score 5 10 Patients Mayo subscore ( finding flexible sigmoidoscopy ) 2 3 Patients received corticosteroid ( referred steroid ) ( p.o. , i.v. , enema , suppository ) within past 6 week Patients difficulty peripheral vascular access Patients receive ACE inhibitor ( least 10 time halflife time interval need initiate treatment ) Patients toxic megacolon Patients malignant disease experience Patients severe cardiovascular disease ( grade III IV Classification heart function New York Heart Association ( NYHA ) ) Patients liver kidney disease ( AST ( GOT ) ALT ( GPT ) total bilirubin creatinine level 2 time high upper limit normal ( abbreviated ULN , hereinafter ) Patients suspect HBV HCV HIV pathogenic bacteria Patients anticoagulant therapy abnormality blood coagulation system ( PT PTT level 1.5 time higher ULN Pregnant woman patient possible pregnancy Breast feeding woman Patients weigh 40 kg less Patients hemoglobin level less 6.5 mmol/L ( 10.5 g/dL ) Patients platelet count le 150 x 103/mm3 , 150 x 109/L ( 15 x 104/mm3 ) Patients white blood cell count le 3.5 x 109/L ( 3,500/mm3 ) Patients hypotension ( systolic blood pressure 80 mmHg less )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Cellsorba EX</keyword>
</DOC>